Log In
BCIQ
Print this Print this
 

Verdeso, desonide (formerly Desilux)

  Manage Alerts
Collapse Summary General Information
Company GlaxoSmithKline plc
DescriptionLow-potency topical steroid formulated with 0.05% desonide in emollient foam delivery vehicle
Molecular Target Not available
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationDermatitis
Indication DetailsTreat atopic dermatitis; Treat mild to moderate atopic dermatitis
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

06/17/2013

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today